BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2544590)

  • 1. Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
    Fesen M; Pommier Y
    J Biol Chem; 1989 Jul; 264(19):11354-9. PubMed ID: 2544590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar sequence specificity of mitoxantrone and VM-26 stimulation of in vitro DNA cleavage by mammalian DNA topoisomerase II.
    Capranico G; De Isabella P; Tinelli S; Bigioni M; Zunino F
    Biochemistry; 1993 Mar; 32(12):3038-46. PubMed ID: 8384486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
    Pommier Y; Capranico G; Orr A; Kohn KW
    J Mol Biol; 1991 Dec; 222(4):909-24. PubMed ID: 1662289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local base sequence preferences for DNA cleavage by mammalian topoisomerase II in the presence of amsacrine or teniposide.
    Pommier Y; Capranico G; Orr A; Kohn KW
    Nucleic Acids Res; 1991 Nov; 19(21):5973-80. PubMed ID: 1658748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distamycin inhibition of topoisomerase I-DNA interaction: a mechanistic analysis.
    Mortensen UH; Stevnsner T; Krogh S; Olesen K; Westergaard O; Bonven BJ
    Nucleic Acids Res; 1990 Apr; 18(8):1983-9. PubMed ID: 2159632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of topoisomerase II catalytic activity by DNA minor groove binding agents distamycin, Hoechst 33258, and 4',6-diamidine-2-phenylindole.
    Woynarowski JM; McHugh M; Sigmund RD; Beerman TA
    Mol Pharmacol; 1989 Feb; 35(2):177-82. PubMed ID: 2465485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of base mutations on topoisomerase II DNA cleavage stimulated by mAMSA in short DNA oligomers.
    Capranico G; Tinelli S; Zunino F; Kohn KW; Pommier Y
    Biochemistry; 1993 Jan; 32(1):145-52. PubMed ID: 8380330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
    Woynarowski JM; Sigmund RD; Beerman TA
    Biochemistry; 1989 May; 28(9):3850-5. PubMed ID: 2473776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides.
    Bell A; Kittler L; Löber G; Zimmer C
    Invest New Drugs; 1996; 13(4):271-84. PubMed ID: 8824345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of minor groove binding drugs on mammalian topoisomerase I activity.
    McHugh MM; Woynarowski JM; Sigmund RD; Beerman TA
    Biochem Pharmacol; 1989 Jul; 38(14):2323-8. PubMed ID: 2473754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of simian virus 40 into cellular DNA occurs at or near topoisomerase II cleavage hot spots induced by VM-26 (teniposide).
    Bodley AL; Huang HC; Yu C; Liu LF
    Mol Cell Biol; 1993 Oct; 13(10):6190-200. PubMed ID: 8413219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two distamycin-ellipticine hybrid molecules on topoisomerase I and II mediated DNA cleavage: relation to cytotoxicity.
    Riou JF; Grondard L; Naudin A; Bailly C
    Biochem Pharmacol; 1995 Jul; 50(3):424-8. PubMed ID: 7646545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding properties of minor groove binders and their influence on the topoisomerase II cleavage reaction.
    Bell A; Kittler L; Löber G; Zimmer C
    J Mol Recognit; 1997; 10(6):245-55. PubMed ID: 9770648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
    Smith PJ; Bell SM; Dee A; Sykes H
    Carcinogenesis; 1990 Apr; 11(4):659-65. PubMed ID: 2157558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure at restriction endonuclease MboI cleavage sites protected by actinomycin D or distamycin A.
    Nilsson MG; Skarped C; Magnusson G
    FEBS Lett; 1982 Aug; 145(2):360-4. PubMed ID: 6290273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topological complexes between DNA and topoisomerase II and effects of polyamines.
    Pommier Y; Kerrigan D; Kohn K
    Biochemistry; 1989 Feb; 28(3):995-1002. PubMed ID: 2540827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of minor groove binding drugs on camptothecin-induced DNA lesions in L1210 nuclei.
    McHugh MM; Sigmund RD; Beerman TA
    Biochem Pharmacol; 1990 Feb; 39(4):707-14. PubMed ID: 1689578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene.
    Pommier Y; Orr A; Kohn KW; Riou JF
    Cancer Res; 1992 Jun; 52(11):3125-30. PubMed ID: 1317259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Base sequence determinants of amonafide stimulation of topoisomerase II DNA cleavage.
    De Isabella P; Zunino F; Capranico G
    Nucleic Acids Res; 1995 Jan; 23(2):223-9. PubMed ID: 7862525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-specific sites of topoisomerase II DNA cleavage in Drosophila chromatin: heterogeneous localization and reversibility.
    Borgnetto ME; Zunino F; Tinelli S; Kas E; Capranico G
    Cancer Res; 1996 Apr; 56(8):1855-62. PubMed ID: 8620504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.